Connect Biopharma [CNTB]
Pivot Data
Pivot Statistics
| Metric | Average | Median | Std Dev |
|---|---|---|---|
| Gain % | 15.04% | 15.02% | 1.36% |
| Loss % | -23.63% | -23.61% | 5.36% |
| Duration | 10.7d | 9d | 6.9d |
| Total Pivots Found | 7 |
| Gain/Loss Legs | 6 (3 Gain / 3 Loss) |
| Last Pivot | Top @ $2.49 on 2026-05-29 |
| Change since Last Pivot | $-0.37 (-14.86%) |
Next Pivot Prediction Last: $2.12
| Predicted Next Type | Bottom |
| Predicted Price (Avg) | $1.90 |
| Predicted Price (Median) | $1.90 |
| Predicted Price Range (~68%) | $1.77 - $2.04 |
| Change to Avg Target | $-0.22 (-10.30%) |
| Predicted Date (Avg) | 2026-06-08 |
| Predicted Date Range (~68%) | 2026-06-01 - 2026-06-15 |
| Basis | Based on 3 historical losses (Avg: -23.63%, Median: -23.61%, StdDev of Abs: 5.36%) and duration (Avg: 10.7 days, StdDev: 6.9 days) |
| Note | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Modest rise for Connect Biopharma.
Connect Biopharma (CNTB) stock price posted modest gains on Friday after the stock rose $0.0200 (0.95%) from the previous session on below-average volume. The stock slightly outperformed the market today, moving slightly ahead of the NASDAQ's 0.31% rise. Yesterday's trading volume was 173 605 shares, worth about $368 043. This represents 171 592 shares less than the day before. Volume was below the 10-day average of 276 988 shares.
Connect Biopharma signals
There is no conclusive signals given from RSI. The price is below both moving averages, and the short-term average is below the long-term average, confirming a sustained down-trend. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (-36.7%), medium- (-36.7%), and long-term (-36.7%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Connect Biopharma Support & Resistance Levels
The stock is approaching the closest resistance level at $2.49. approximately $0.370 (17.45%) away. Approaching it. Breaking above this level could signal further upside where next resistance level will be found at $2.91. On a fall back there will be support at $1.52 The dis das resistance s11.52 -
Connect Biopharma Evaluation
- Short score: -3.27
- Medium score: -4.12
- Long score: -3.33